The ability to precisely modify the genome in a site-specific manner is extremely useful.
Introduction
The ability to make precise double-strand breaks (DSBs) in the genome is extremely useful for genome engineering, as this ability can facilitate directed changes in the genome for applications ranging from studying a gene to engineering an entire biosynthetic pathway. The most popular tools for making DBSs are currently zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeat (CRISPR)/Cas9 system.
Of these three, the CRISPR/Cas9 system offers the greatest ease of use.
The CRISPR/Cas9 system, a component of the bacterial RNA-mediated adaptive immune system, consists of transcribed guide-RNAs derived from integrated fragments of phage and plasmid DNA that direct the Cas9 RNA-guided DNA endonuclease to targets containing complementary sequences to the CRISPR (Barrangou et al., 2007; Jinek et al., 2012) .
The complex requires a protospacer adjacent motif (PAM) downstream of the target sequence to begin binding (Sternberg, Redding et al., 2014) . Upon binding, Cas9 generates a blunt DSB three to four bases upstream of the PAM through the use of RuvClike and HNH nuclease domains (Jinek et al., 2012) .
Recently, the CRISPR/Cas9 system from Streptococcus pyogenes has been adapted for genome editing (Jinek et al., 2012; Mali, Yang et al., 2013; Jinek et al., 2013; Cong et al., 2013) , and has been successfully used in many eukaryotes (Friedland et al., 2013; Kim, Ishidate et al., 2014; Zhang, Koolhass, and Schnorrer, 2014; Gratz, Ukken et al., 2014; DiCarlo et al., 2013; Harel et al., 2015) , as well as in disease and therapeutic modeling (Xue, Chen, Yin et al., 2014; Heckl et al., 2014; Platt, Chen et al., 2014; Ousterout et al., 2015; Hu, Kaminski et al., 2014; Wang and Quake, 2014) . However, the spectre of off-target cleavage may present significant challenges to the use of CRISPR/Cas9 in these applications. The chimeric single-guide RNA (sgRNA) not only tolerates mismatches, insertions, and deletions throughout its target sequence, particularly outside of the seed sequence, but may also display cell type-specific offtarget effects (Fu et al., 2013; Hsu et al., 2013; Pattanayak et al., 2013; Cho et al., 2014; Wu et al., 2014; Kuscu, Arslan et al., 2014; Cencic, Miura et al., 2014) . Contrary to these observations, off-target cleavage in murine embryos and human induced pluripotent and embryonic stem cells (hiPSCs and ESCs) has been reported to be extremely rare (Yang, Wang et al., 2013; Veres et al., 2013; Xie et al., 2014; Yang, Grishin, Wang et al., 2014) .
This discrepancy may be explained by the underlying repair mechanism of CRISPR/Cas9induced DSBs. Typically, these DSBs are thought to be repaired by error-prone NHEJ, similarly to those generated by the FokI domains of TALENs and ZFNs (Jinek et al., 2013; Mali, Yang et al., 2013; Cong et al., 2013) . However, Cas9 makes blunt DSBs, whereas FokI dimers make overhangs. Thus, these blunt, chemically unmodified DSBs could be repaired by the precise NHEJ pathway, which has been previously demonstrated using the Tn5 transposon system, which also makes blunt DSBs (van Heemst et al., 2004) .
Indeed, precise NHEJ has been observed to resolve the majority of CRISPR/Cas9-induced translocation events in human immortalized cells (Ghezraoui et al., 2014) . Additionally, the predominant use of precise NHEJ may explain the relatively low level of errorprone editing observed in hiPSCs (Mali, Yang et al., 2013 ).
There appears to be a large amount of variation in sgRNA efficiency, as measured by errorprone repair between different cell types (Mali, Yang et al., 2013) . Because Cas9-mediated cleavage generates DSBs with blunt ends, we hypothesized that the errorprone NHEJ is a by-product of the propensity of Cas9 to remain bound to its target DNA sequence after cleavage (Sternberg, Redding et al., 2014) . Thus, precise NHEJ should be the contributing factor to resolving a significant percentage of Cas9-mediated DSBs, potentially explaining the large degree in variation. We further hypothesized that precise NHEJ could be exploited to increase the specificity of Cas9based genome editing, which has also been suggested based on experiments in zebrafish (Auer et al., 2014) .
Additionally, we sought to restrict the window of Cas9 activity to limit both the amount of potential off-target activity and DNA-damage-associated cell cycle delay, which has been demonstrated in budding yeast (Demeter et al., 2000) .
Here, we demonstrate that, by generating two DSBs with two different sgRNAs at the same time, both large and small precise deletions can be generated, that these DSBs can be exploited to knock in various expression cassettes and gene modifications through precise NHEJ, and that this strategy is applicable in both human and mouse cells.
Additionally, we present a destabilized variant of Cas9, which we originally designed to facilitate greater control over genome modification, but which was repurposed for investigation of the repair dynamics and outcomes of Cas9-mediated DSBs.
Results

Patterns of Excision and Repair Resulting from Paired PAM Orientations
Because Cas9 generates blunt DSBs, we hypothesized that these blunt ends would be preferentially repaired by precise NHEJ. To test this hypothesis, we chose to generate two DSBs within the same locus rather than one because precise NHEJ mediated by one individual sgRNA would be indistinguishable from uncleaved DNA at the sequence level. However, if a cell received two sgRNA vectors expressing two different sgRNAs, there would be a high probability of excision of the intervening sequence between the paired sgRNA targets, allowing for religation of the genomic junctions and subsequent detection and analysis via PCR and Sanger sequencing ( Figure 1A ). Others (Cong et al., 2013; Mali, Yang, et al., 2013; Canver, Bauer et al., 2014) have also observed this resulting excision and religation. This excision may occur because Cas9 appears to bind the PAM side of the DSB less strongly after cleavage (Sternberg, Redding et al., 2014) . A high level of precision has also been observed in translocations generated by two sgRNAs (Ghezraoui et al., 2014) .
However, the repair consequences of paired PAM orientations resulting from using two sgRNAs simultaneously have not been explored. For pairs of sgRNAs, there are four possible orientations: 1) PAMs Out, 2) PAMs In, 3) PAMs 5', and 4) PAMs 3' ( Figure   1B ). It is important to note that PAMs 5' and PAMs 3' are functionally equivalent at first glance. Because
Cas9 can cleave at either the third or fourth base upstream of the PAM, precise rejoining can occur with 0, +1, or -1 bases on each of the repaired genomic ends, depending on which PAM orientation is used. As such, each orientation has four possible outcomes for precise repair (detailed in Figure 1B and shown as 5'sgRNA bases/ 3' sgRNA bases). To this end, we generated multiple sgRNAs against the 3'UTRs of human MYOD1, PAX3, PAX7, and mouse Utrophin (Utrn) to examine the repair patterns and degree of precision utilized by paired PAM orientations ( Figure   1C -E).
To date, the largest study of repair patterns of paired PAM-mediated excisions focused only on the PAMs 3' orientation (Canver, Bauer et al., 2014) . In our study, we first sought to examine if there were any large differences in repair patterns between all four orientations. Each pair was tranfected separately into showed the highest frequency of precise repair, reaching 96.15%, whereas PAMs 3' showed the lowest frequency of precise repair (Figure 1Cii ). Imprecise repair was mainly limited to small deletions and occasional inclusion of bases that should have been excised. PAMs Out and PAMs 3' displayed a deviation from 0/0 precise repair, with both possessing a mostly 0/+1 precise repair pattern, which may be the result of them sharing the same 3' sgRNA ( Figure 1Ciii ).
Interestingly, the predominance of 0/+1 precise repair observed with PAMs 3' appears to be due to 0/0 repair generating a perfect target site for the 5' sgRNA in this pair. Comparing the deviations from 0/0 precise repair between PAM orientations revealed that there was a significant difference between distributions (P < Having observed that all four orientations were capable of facilitating precise repair at one locus, we next asked if different paired PAMs in the same orientation would display the same degree of repair precision at the same locus. Thus, we utilized four pairs of sgRNAs in the PAMs In orientation at the PAX3 3'UTR in HEK293 cells (Figure 1Di ). We observed that the vast majority of sequenced deletioncontaining amplicons for all four pairs were remarkably precise, with the frequency of precise repair ranging from 87.5% to 100% (Figure 1Dii ;
Figure 1-figure supplement 2). Interestingly, we did not observe insertions in any of these sequenced amplicons. We observed that there was a significant difference between the distributions of deviations (P < 0.0001; Kruskal-Wallis test), but that only PAMs In #1 displayed a noticeable deviation from 0/0 precise repair. The majority of these sequenced amplicons were of the 0/-1 precise repair variety, which was found to be significantly different than that of the other three pairs (P < 0.004 for PAMs In #1 versus each other pair; post hoc Dunn's multiple comparisons test for all comparisons; Figure 1Diii ). These findings provide additional evidence for both the high degree of precision involved in CRISPR/Cas9-induced NHEJ repair, and that differences in repair are dependent on individual sgRNAs, possibly based on target sequence.
Having observed that CRISPR/Cas9-induced NHEJ repair does not appear to be inherently errorprone, we next sought to examine whether a given pair of sgRNAs generates similar repair patterns in different cell types. Thus, we designed pairs of sgRNAs against the PAX7 3'UTR, which were subsequently transfected into HEK293 cells and H9
human ESCs (hESCs) ( Figure 1Ei ). We observed a mostly high level of precise repair in the H9 hESCs, with only one pair resulting in less than 75% precise repair ( Figure 1Eii ; Figure However, we observed what appeared to be a more varied level of precise repair in HEK293 cells with the same PAM pairs, ranging from 44.44% to 90.48%
( Figure 1Eii ). Additionally, we only observed two typical error-prone events for HEK293, one resulting from the use of PAX7r1-4 and a double event for
PAX7r1-4 and PAX7r1-1 ( Figure 1-figure supplement 3). For H9 hESCs, we observed two typical error-prone repair events: one for PAX7r1-2 and one for PAX7r1-3 ( Figure 1-figure supplement 4 ). In spite of this variation, deviation from 0/0 precise repair was not significant for any given pair between cell types. In fact, for each pair, the deviation from 0/0 precise repair was not significantly different between cell types (P > 0.8 for all four comparisons; Dunn's multiple comparisons test; Figure 1Eiii ). These data illustrate that a given pair of sgRNAs generates similar patterns of repair with similar degrees of precision in different cell types of the same species.
Given that we observed a high degree of precise repair in human cells across three loci and 16 pairs of sgRNAs, we sought to examine if a high level of repair precision would also be observed in mouse cells. Paired sgRNAs have been previously utilized to generate deletions in murine embryos, although there was significant variability in deletion size between embryos .
To examine repair patterns in mouse cells, we transfected C2C12 murine immortalized myoblast cells with three pairs of sgRNAs in different orientations against the mUtrn 3'UTR ( Figure 1Fi ). We observed not only a more varied pattern of repair than with human cells (precise repair ranged from 41.67% to 100% of amplicons; Figure 1Fiii ). Interestingly, we found that there was no significant difference between the distributions of deviance from 0/0 precise repair for the three orientations (P = 0.1354; Kruskal-Wallis test). These results indicated that CRISPR/Cas9 facilitates a high level of repair in murine cells as well, but may potentially have generated a more varied distribution of imprecise repair due to species-specific differences in NHEJ repair.
Knock-in Blunt Ligation: CRISPR/Cas9-
Mediated in vivo Blunt-End Cloning
Because of the high level of precise NHEJ repair we observed, we asked if we could exploit this apparent in vivo blunt-end ligation to replace endogenous sequences precisely with linear exogenous sequences in a homology-independent manner using CRISPR/Cas9 (Figure 2A) . A similar method has been developed in zebrafish using plasmid DNA in which the same sgRNA is used to cleave both the genome and the plasmid, ultimately resulting in homologyindependent knock-in of the plasmid, albeit with reduced levels of perfect ligation (Auer et al., 2014) .
To test this idea and examine the level of repair precision, we constructed an expression cassette consisting of the mouse PGK promoter driving expression of the Puro R ΔTK fusion gene linked via a P2A skipping peptide to mCherry, followed by the rabbit beta globin terminator sequence (PTKmChR).
We also constructed another cassette containing the same sequences, but flanked by a phiC31 attP site upstream of the PGK promoter and a Bxb1 attP site downstream of the terminator sequence for the initial purpose of generating a selectable landing pad that did not rely on homology arms for integration (DICE-EPv2; Figure 2B ). Each cassette was amplified via PCR with 5' phosphorylated primers, purified, and subsequently co-transfected into HEK293 cells with various sgRNA/Cas9 constructs, singly or in pairs, before being subjected to flow cytometric analysis and junction PCR, followed by Sanger sequencing ( Figure   2C ). In this set of experiments, we utilized sgRNAs targeting the PAX7 3'UTR ( Figure 2D ). For the DICE-EPv2 cassette, flow cytometric analysis revealed that the percentage of mCherry + cells was increased above cassette alone (0.20 ± 0.15%) for sgRNAs PAX7r2-1 and PAX7r3-2, both alone and paired (referred to as PAMs Out Large) with a range 1.61-2.67% two days post-transfection, and that the percentage of mCherry+ cells could be further increased to 17.80-24.50% with four days of puromycin selection , albeit at the risk of increasing selection for random integration ( an absence of precise cassette junction repair, whereas knock-in blunt ligation of PTKmChR cassette resulted in a high level of precise genomic junction repair (93.75%) and an appreciable degree of precise cassette junction repair (37.5%; Figure 2Hi and ii). We speculated that the lack of precise cassette junction repair with DICE-EPv2 was attributable to the formation of hairpin structures by the palindromic AttP sites. Such hairpins could be unfavorable to direct end-joining. Thus, these hairpins would be more subject to removal by nucleases. Additionally, we observed one instance of an insertion of part of the pX330 plasmid (similarly to that observed in Canver, Bauer et al., 2014) . These results indicated that the blunt DSBs generated by the CRISPR/Cas9 system could be exploited in mammalian cells to knock-in PCR cassettes in a homology-independent manner.
We observed that cassettes were knocked into the genome in both orientations, indicating that ligation by precise NHEJ lacks directionality, as expected due to lack of homology arms on our cassettes ( (both from Lam et al., 2012) , mKOκ (Tsutsui et al., 2008) , mCardinal (Chu et al., 2014) , and mCerulean (Rizzo et al., 2004) due to minimal spectral overlap and (for the most part) brightness. These cassettes were less than 2 kb in size and could be readily amplified from template plasmid and easily purified.
We called these cassettes the pKER (polymerasechain-reaction-based Knock-in EF1α-RBG terminator) series, and they are depicted by brightness in Figure   3A .
To quickly assess the suitability of the pKER series for KiBL, we used pKER-mKOκ to investigate the effects of the orientation of the paired PAMs as well as the effects of the cassette's phosphorylation status on the efficiency of KiBL, using the percentage of positive cells as a proxy. We reasoned that Figure 3B ), which was previously identified as a safe harbor site in the human genome .
H11 is an intergenic locus between DRG1 and 
Stabilized Cas9-DD Combined with Nuclease Protection Facilitates a Higher Degree of Precise Repair at the Genome-Cassette Junction
We and others have observed that, in utilizing the CRISPR/Cas9 system, successful modifications of one allele appeared to coincide with undesired mutations in the sister allele (unpublished data; Canver, Bauer et al., 2014) . The duration of Cas9 activity may be responsible for these additional modifications. Thus, we initially sought to generate a more temporally controllable Cas9. We chose to utilize the FKBP12 L106P destabilization domain because it was relatively small, has been shown to be effective at destabilizing a wide range of proteins, and its stabilizing ligand, the small molecule Shield-1, was relatively inexpensive and had virtually no effect on cell viability, as well as good intracellular availability and potency (Banaszynski et al., 2006; Maynard-Smith et al., 2007) . We initially chose to fuse the destabilization domain to the C-terminus of SpCas9 because we desired a version of Cas9 that possessed some residual stability in the absence of Shield-1 (Banaszynski et al., 2006) . The resulting fused domain was in close proximity to the PAM-binding domain of SpCas9 (Anders et al., 2014) . We called this comparisons test). Interestingly, we did not detect any significant difference between Cas9-DD and WT-Cas9
for the percentage of Clover+ cells or for normalized MFI ( Figure 4D ). Additionally, we did not detect any significant difference between the presence and absence of 1 μM Shield-1 with Cas9-DD.
Having already observed that WT-Cas9 facilitated knock-in blunt ligation of linear cassettes, we next sought to determine the effect of Cas9-DD at the molecular level. To this end, we examined the 5' PAX7 genomic-5' pKER-Clover junction resulting from KiBL using unphosphorylated cassettes with WT-Cas9 or destabilized Cas9-DD with our sgRNAs ( Figure 4E , Figure 4 -figure supplement 2). We did not examine junctions using stabilized Cas9-DD at this time as we reasoned that its junctions would resemble those of WT-Cas9. Additionally, we examined whether the addition of three phosphorothioate bonds in the 5' ends of the primers used to amplify the cassettes affected the precision of the cassette side of the junction by protecting the cassette from nuclease degradation. We observed that unprotected cassettes co-transfected with WT-Cas9 resulted in precise genomic junctions, but imprecise cassette junctions in 100% of observed amplicons ( Figure 4F ).
Interestingly, protecting the 5' ends of the cassette only resulted in a relatively modest increase in precise genomic/precise cassette junctions (40% of amplicons) when using WT-Cas9 ( Figure 4F ). When destabilized Cas9-DD was used in conjunction with phosphorothioate bonds, we observed a greater increase in precise genomic/precise cassette junctions (60% of amplicons), but, surprisingly, we also observed a slight increase in imprecise genomic/imprecise cassette junctions (20% of amplicons; Figure 4F ). These results appeared to demonstrate that the use of destabilized Cas9-DD, along with the addition of nuclease protection to the pKER cassettes, facilitated a higher degree of cassette junction precision in KiBL.
KiBL results in efficient, precise knock-ins in human induced pluripotent stem cells
Having observed that the CRISPR/Cas9 system could facilitate the precise knock-in of cassettes in an immortalized cell line, we sought to apply KiBL to human iPSCs (hiPSCs). The successful application of such a method would provide a viable alternative to traditional nuclease-mediated homologous recombination (HR). We chose a line of hiPSCs generated from a healthy donor that we refer to as JF10, and chose H11 as our target locus utilizing the Cas9. FACS analysis revealed that the Clover+ cells formed a mostly discrete population in these hiPSCs ( Figure 5D ). Additionally, the percentage of Clover+ cells was always observed to be less than 0.5% of live cells ( Figure 5E ). This low percentage may be due both to the relatively low amount of transfected cassette (200ng) and the lower electroporation efficiency of linear double-stranded DNA. However, we found that there was a significant difference between the mean percentages of Clover+ cells (P = 0.0193; ordinary one-way ANOVA), but that only the mean percentages of cassette alone (0.069%) and Cas9-DD + 0.5 µM Shield-1 (0.147%) were significantly different from each other (P = 0.019; post hoc Tukey's multiple comparisons test). In order to analyze precise endjoining at the junctions, we carried out targeted genomic amplification on pooled Clover+ cells by amplifying across the H11 locus in order to capture all of the KiBL events ( Figure 5F ). Subsequent analysis of the H11 5'-Clover 5' junction revealed that, in the presence of Shield-1, Cas9-DD-induced DSBs resulted in the precise joining of both the genomic and cassette sequences, but that the absence of Shield-1 resulted in the loss of the PAM and the three bases preceding it on the genomic side, but no loss of bases on the cassette side ( Figure 5G ). Additionally, the use of destabilized Cas9-DD appeared to result in a C-to-T mutation nine bases 5' of the PAM. We have only observed this mutation with Cas9-DD in the absence of Shield-1.
Bulk sequencing of the Clover 3'-H11 3' junction for stabilized Cas9-DD also showed precise joining of the We recognized that there was the possibility that we were repeatedly sampling and sequencing the same clonal population in our initial hiPSC KiBL experiments. We attempted to rule out this possibility in three ways. First, we carried out single-cell PCR across the H11 locus utilizing FACS to sort single cells into wells of 96-well plates. From this experiment, we identified two cells that underwent KiBL: one originated from treatment with stabilized Cas9-DD (cell I), the other from destabilized Cas9-DD (cell II) ( Figure 6A ). Cell I, interestingly, appeared to have only received the 5' sgRNA/Cas9-DD vector and had precise genomic and cassette junctions for both the 5'-5' and 3'-3' junctions. Sequence analysis revealed that cell II received both sgRNA vectors and possessed a precise 5' genomic junction, but was lacking four bases of the 5' cassette junction. Interestingly, the 3' cassette junction was precise, but the 3' genomic junction appeared to have been cut 16 bases downstream of the actual PAM site for the 3' sgRNA ( Figure 6A ). In both cells, the other allele appeared be completely unmodified except for an additional adenosine present at the cleavage site of the 5' sgRNA, potentially as the result of error-prone NHEJ.
To further examine the level of clonality generated by KiBL, we took advantage of the pKER cassettes' limited spectral overlap and co-transfected 1) pKER-Clover and pKER-mKOκ, and 2) pKER-Clover, -mKOκ, and -mCardinal with our H11 PAMs
Out sgRNA pair into JF10 hiPSCs, which were subsequently analyzed via FACS.
In the first condition, we observed that Clover+mKOκ-and Clover-mKOκ+ cells were roughly equivalent in relative frequency and that Clover+mKOk+ cells made up a smaller frequency of the population ( Figure 6B ).
Interestingly, in the second condition, we observed all three possible single-positive populations, and no double-or triple-positive populations ( Figure 6C ).
These data illustrated that there were at least three clones in each experiment.
To address clonality at the molecular level, we employed an approach using pKER-Clover cassettes containing 6-base barcodes and 50-base homology arms. Homology arms of this size have been previously used with the CRISPR/Cas9 system to facilitate homologous recombination in human immortalized cell lines (Zheng, Cai et al., 2014) and
mouse ESCs . After co-transfection with the H11 PAMs Out sgRNA pairs and Cas9-DD, followed by isolation with FACS, sequence analysis of the 5' genomic-5' Clover junction revealed that HR occurred several times ( Figure 6D ). After isolation with FACS, PCR amplification of the 5' genomic-5'
Clover junction, and subsequent subcloning, we observed 11 different barcodes in 12 sequenced amplicons ( Figure 6D ). Out of these, 11 had a thymine (the human reference allele, which we had placed in the 5' homology arm) instead of cytosine (the allele possessed by JF10) in the position prior to the PAM that differed from reference, indicating that homologous recombination did indeed occur. We also observed that both alleles underwent HR, as indicated by detection of both alleles of our allele-specific T/C SNP on the 5' side of the locus. Additionally, we observed one non-barcoded KiBL event and a barcoded KiBL event where the cassette appeared to lack at least the 5' homology arm. We did not observe 
Analysis of Off-Target KiBL Events
Because KiBL utilizes the CRISPR/Cas9 system, there was a concern that off-target cleavage would result in the uptake of cassettes at sites other than the targeted locus. Indeed, such events have been observed in HEK293T cells using the GUIDE-seq method for unbiased identification of CRISPR/Cas9 off-target cleavage events (Tsai et al., 2014b) . We chose to examine the top six off-target sites for each sgRNA in the H11 PAMs Out pair as determined by the MIT CRISPR Design tool. For each off-target site, we attempted to amplify the 5' genomic-5' cassette, 3' genomic-5' cassette, 5' genomic-3' cassette, and 3'genomic-3' cassette junctions, which led to 48 offtarget reactions per sample. In order to perform such a large number of assays, we used the multiple displacement amplification variation of whole genome amplification to ensure that there would be enough DNA. We analyzed seven pools of Clover+ cells: one pool treated with WT-Cas9, two pools treated with destabilized Cas9-DD, two pools treated with Cas9-DD and 0.5 μM Shield-1, and two pools treated with Cas9-DD and 1 μM Shield-1. We were unable to detect offtarget KiBL events at the vast majority of predicted junctions, with the exception of faint detection of the 3'H11 sgRNA OT4 genomic reverse primer-3'pKER cassette junction (Figure 7) . These data suggest that, at least in hiPSCs, KiBL occurred predominantly at the on-target locus. It is also possible that the frequency of KiBL off-target events fell below the sensitivity of our assay.
Discussion
We demonstrated in this work that the blunt cleavage activity of the CRISPR/Cas9 system mediates repair with a high degree of precision and can be exploited to precisely insert exogenous sequences into the genome through knock-in blunt ligation. We found that all four paired PAM orientations are capable of facilitating precise repair and that precise repair can be observed in both human and mouse cells.
We then demonstrated that PCR amplicons lacking homology arms can be used to precisely replace the sequence between sgRNA targets and that this in vivo blunt-end cloning functions in an immortalized cell line and in hiPSCs. Lastly, we developed a variant of Cas9 fused to a destabilization domain with the initial goal of facilitating a greater degree of control over Cas9 activity.
Other strategies utilizing the CRISPR/Cas9 system to facilitate knock-in of exogenous sequences into the genome have relied on knocking in plasmid DNA through NHEJ (Auer et al., 2014) or microhomology-mediated end-joining (Nakade et al., 2014) . In general, the plasmid-based methods rely on in vivo cleavage of a plasmid donor to mediate integration, which was previously demonstrated with ZFNs (Cristea et al., 2012) . These methods introduce additional undesired sequence into the cell through the plasmid backbone, whereas KiBL only introduces the knock-in cassette and the sgRNA/Cas9 vector.
Additionally, the Cas9 nickase has been used to knockin a double-stranded oligonucleotide (dsODN) with overhangs in a strategy similar to the ObLiGaRe method used with ZFNs, albeit with relatively low efficiency (Ran, Hsu et al., 2014; Maresca et al., 2013) .
Our observation that unphosphorylated cassettes are capable of ligating into CRISPR/Cas9-induced DSBs at relatively high frequency in HEK293 cells appears to contradict observations in the GUIDE-seq method (Tsai et al., 2014b) . However, this finding can be explained by our much larger cassettes: our unprotected, unphosphorylated cassettes may be much less negatively affected by endogenous nucleases than the 34-bp GUIDE-seq oligos.
Another set of methods for knock-ins has been developed around exploiting HR and HDR. In cultured Drosophila cells, the use of PCR amplicons containing homology arms has been used to great effect (Böttcher et al., 2014) , which is similar to what has been observed with human immortalized cell lines and mouse ESCs (Zheng et al., 2014; Li et al., 2014) . A subset of these methods has focused on increasing HDR frequency through cell cycle synchronization (Lin, Staahl et al., 2014) and by inhibition of the NHEJ machinery (Chu et al., 2015; Maruyama et al, 2015) .
Our method offers the advantage of functioning during the G1, S, and G2 phases of the cell cycle, whereas the HR and HDR strategies are restricted to late S and G2 phases. Thus, our method may be particularly useful in non-dividing cells, such as neurons where the application of Cas9 has been limited to generating mutations through error-prone repair (Swiech, Heidenreich et al., 2014) .
Targeted genome engineering has the potential to be a useful tool for research, therapeutic, and industrial applications. The CRISPR/Cas9 system has the advantages of being relatively inexpensive and easy to use, but may have larger off-target effects than TALENs or ZFNs. Several approaches have been put forward to restrict off-target cleavage, including simply using less sgRNA and Cas9, using truncated sgRNAs for increased specificity, using paired nickases, controlling Cas9 expression through the inducible Tet-ON system, and splitting Cas9 in half Fu et al., 2013; Zhu, Gonzalez, and Huangfu, 2014; Wright, Sternberg et al., 2015;  Zetsche, Volz, and . Tet-ON induction, however, generates a large amount of mRNA, which could lead to an increase in Cas9 off-target activity.
The split-Cas9 variants, while potentially being more controllable, have substantially reduced cleavage activity, relying on either the sgRNA or rapamycin to bind the two halves together (Wright, Sternberg et al., 2015; Zetsche, Volz, and Zhang, 2015) . Our destabilized Cas9 retains the simplicity of requiring only two expression cassettes, rather than three or four. Additionally, Shield-1 itself does not induce any undesired responses when applied to cells in culture or in animals, unlike rapamycin, (Banaszynski et al., 2006; Maynard-Smith et al., 2007; Banaszynski et al., 2008) . During the preparation of this manuscript, a fifth variant was developed using an evolved liganddependent intein to restrict the activity of Cas9 until the binding of the ligand (in the form of 4hydroxytamoxifen) results in the cleavage of the intein and activation of Cas9 (Davis et al., 2015) . Cas9 as it searches for its programmed target site.
Cas9 has been found to probe potential binding sites by finding PAMs (Sternberg, Redding et al., 2014) , and unbiased interrogation of Cas9 cleavage sites in HEK293 cells has revealed that SpCas9 can recognize non-canonical PAMs (Tsai et al., 2014b) . Additionally, experiments in C. elegans have demonstrated that choosing sgRNAs that target loci enriched with potential PAMs increases successful editing (Farboud and Meyer, 2015) , which was motivated by the observation that Cas9 can be sequestered by competitor DNA containing a high density of PAM sequences (Sternberg, Redding et al., 2014) . Those which appears to be mediated in part by Dnmt3a (Ramsahoye et al., 2000) . Additionally, homologous recombination of direct repeats of GFP facilitated by I-SceI in mouse ESCs has been found to stimulate de novo methylation through Dnmt1 that leads to silencing of the recombined cassette (Cuozzo, Porcellini et al., 2007) . These findings combined with the consistent presence of the mutation when using destabilized Cas9-DD lead us to speculate that DSBs induced by destabilized Cas9-DD could be repaired in a different manner than those of WT-Cas9 and stabilized Cas9-DD. Additionally, the lack of knock-in events when using destabilized DD-Cas9 suggests that DD-Cas9 may be preferable for restricting Cas9
activity. This observation is in accordance with the initial work of Banaszynski et al. (2006) describing Nterminal DD fusions as inherently less stable than Cterminal fusions.
Analyzing cells in bulk is informative, but it lacks the resolution only possible at the single-cell (or -clone) level. When working with hiPSCs, single-cell analysis is possible, albeit rather difficult, as the current method for obtaining pure clones is to singlecell sort cells into numerous 96-well plates and analyze the survivors once colonies have formed. The use of a sib-selection-based strategy for enrichment of modified cells is useful, but this strategy is dependent on subsequent subcloning for isolating a pure population as well (Miyaoka et al., 2014) . Thus, in our analyses, we investigated the consequences of KiBL via single-cell PCR. Cell I was found to have only received the 5'sgRNA vector, but the cassette was knocked-in precisely without loss of any nucleotides, underscoring that KiBL is compatible with single sgRNAs as well.
Cell II received both sgRNA vectors, and the modified allele possessed a precise 5' genomic-imprecise 5' cassette junction and a 3' precise cassette-imprecise 3' genomic junction, which is somewhat consistent with destabilized Cas9-DD targeting a nearby incorrect PAM. Interestingly, in both cells, the other allele was wholly correct except for an additional A at the cleavage site of the 5' sgRNA. It is possible that this additional A is the result of error-prone NHEJ or that there is a small subpopulation of cells in culture that acquired an A at this position undergoing KiBL.
Further analysis involving deep sequencing and more single-cell PCR would have to be carried out to determine which actually occurred. It is worth noting that single-cell cloning is the major obstacle to the application of the CRISPR/Cas9 system to hiPSCs.
Additionally, our analysis suggests that multi-sgRNA KiBL may benefit from having both sgRNAs present within the same vector, similar to what has been developed for multiplexed editing using lentiviral vectors (Kabadi et al., 2014) .
In this work, we chose to identify off-target Tsai et al., 2014b) .
Whole genome sequencing would identify the offtarget KiBL events, in addition to error-prone offtarget cleavage repair, but its cost makes it prohibitive for hiPSCs, and the additional information may not be worth the increased cost, as error-prone off-target repair appears not to occur at high frequency in hiPSCs and primary stem cells (Mandal et al., 2014; Yang, Grishin, Wang et al., 2014) . There are currently three unbiased methods for identifying off-target cleavage events: GUIDE-seq, Digenome-seq, and identification through integrase-deficient lentiviral vectors (Tsai et al., 2014b; Kim et al., 2015; Wang et al., 2015) . GUIDE-seq and identification through integrase-deficient lentival vectors are functionally similar, and it does not escape us that KiBL could be used in a similar approach. Ideally, this would be combined with a linear amplification-based method to maximize sensitivity. Such a strategy has been previously used to examine translocations generated by TALENs and CRISPR/Cas9 and to measure the frequency of promoterless gene targeting using adenoassociated virus vectors (Frock et al., 2014; Barzel et al., 2015) .
While being able to place exogenous sequences at any genomic location is useful, being able to knockin sequences at loci where transgenes do not disrupt endogenous gene regulation (known as safe harbor sites) is also useful. We chose the H11 as our target locus because it has previously been identified as a safe harbor site in the human and mouse genome Tasic et al., 2011) . The use of a safe harbor site is of great importance for the placement of transgenes in cell therapies because of the potential for the integration event itself to perturb endogenous genes in a possibly oncogenic manner (for further information see Sadelain, Papapetrou, and Bushman et al., 2011) . Additionally, the gene order of the H11 locus appears to be highly conserved, particularly with respect to mammals and through vertebrates in general. For example, the order appears even to be conserved in the coelacanth. This conservation makes H11 particularly attractive as a genome engineering site.
Ultimately, we have presented a method for utilizing the CRISPR/Cas9 system to facilitate in vivo blunt-end cloning in precise, homology-independent manner through NHEJ. This method, KiBL, is made possible by the ability of Cas9 to make blunt DSBs, which we and others have exploited using two sgRNAs at once to facilitate precise excision of the intervening sequence (Cong et al., 2013; Mali, Yang et al., 2013; Canver, Bauer et al., 2014; Zheng, Cai et al., 2014) .
The main advantages of our method are its relatively high frequency of precise genomic-cassette junctions, its lack of incorporation of additional exogenous sequences, and its independence from sgRNA efficiency. Additionally, KiBL may prove amenable to high-throughput applications, whereas HR is not, due to the necessity of constructing homology arms for each targeted locus. This construction is of particular concern for the concept of saturation editing, which could become very expensive for targeting large numbers of loci (Findlay, Boyle et al., 2014) . Cells were passaged as clumps every three to four days with Versene (Life Technologies) at a 1:6 split.
Detection of CRISPR/Cas9-Facilitated Excision.
HEK293 and C2C12 cells were transfected using FuGene HD 
Detection of Knock-in Blunt Ligation and
Homologous Recombination. For HEK293 cells,
FuGene HD was used to transfect cells as described above, using 100 ng of cassette and 1.5 µg of each sgRNA/Cas9 vector for a total of 3.1 µg of DNA. 500,000 cells had been plated one to two days prior to transfection. Reactions were carried out in triplicate. Shield-1 (Clontech) was added to the cells immediately prior to transfection at a concentration of 1 µM. Puromycin (Life Technologies) selection was started two days after tranfection at a concentration of 1µg/mL and carried out for four days with fresh media and antibiotic being replaced every two days. Cells were analyzed by flow cytometry two days after transfection or six days in the case of puromycin-selected cells. Briefly, cells were trypsinzed with 0.05% trypsin, resuspended in PBS (Thermo Fisher Scientific) with 2% FBS, and were filtered before analysis to remove clumps and debris. gDNA was isolated from the remaining cells with the DNeasy Blood and Tissue Mini Kit. Genome-cassette junctions were amplified with Q5 Hi-Fidelity polymerase using at least 100 ng of DNA per reaction. Amplicons were subjected to gel electrophoresis, excised, purified, subcloned, transformed, and sequenced as described above. Primers used appear in Table 5 .
JF10 cells were plated three to four days prior to electroporation on vitronectin-coated 6-well plates. Cells were incubated at least one hour beforehand with Essential 8 media containing 10 µM ROCK inhibitor Y-27632. Cells were then dissociated into single cells with Versene. Cells were resuspended in the homemade nucleofector buffer described in Zhang, Vanoli et al., 2014, with Table 5 . polymerase. Off-target primers appear in Table 6 .
Analysis of Off-Target KiBL
Western Blotting. HEK293 cells in 6-well plates that had been plated two days prior were transfected using FuGene HD with 5 µg of plasmid encoding the H11-r1-2 sgRNA and WT-Cas9, Cas9-DD, or DD-Cas9 as described above. Cas9-DD and DD-Cas9 were transfected in duplicate. All wells received 0.5 µM Shield-1 except one replicate each for Cas9-DD and DD-Cas9. The following day, media was aspirated and replaced with fresh media containing 0.5 µM Shield-1 for all wells except for the replicates that did not receive Statistics. All statistical analysis was carried out using GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA). Sequence analysis KiBL events at 5' H11-5' pKER junction resulting from the use of stabilized Cas9-DD and barcoded UPT-Clover cassettes possessing short 50 bp homology arms. Red denotes allele-specifc SNPs (also indicated by an arrow), violet denotes HR-mediated conversion of a base (also indicated by an arrow), blue denotes a base HR-mediated insertion, orange denotes a common index sequence, green denotes the barcode sequence, turquoise denotes the 5' cassette sequence, dashes indicated unobserved sequence. PAM is underlined. Table 4 . Excision detection primers. All oligos are in the 5' to 3' direction. Table 5 . Primers for Amplifying Cassette Junctions. All oligos are in the 5' to 3' direction and are to be used in conjunction with the genomic primers in Table 4 .
Primer Name Sequence
MYOD1
Primer Name Sequence
DICE-EP-detection-mch-fwd GACATCCCCGACTACTTGAAGC PGK-rev1 AAAGAACGGAGCCGGTTGG pKER-detector-5' TACACGACATCACTTTCCCAGTTTA pKER-clover-detector-3' CAACCACTACCTGAGCCATCAGTC pKER-detector-5'-NP TACACGACATCACTTTCCCAGTT*T*A pKER-clover-detector-3'-NP TAACCACTACCTGAGCCATCAG*T*C mKOk-AS-N2 CACCTTCAATTGTGAACTCATGCCCATTG Table 6 . Off-target sites and primers for H11-r1-2 and H11-r2-3. All oligos are in the 5'-3' direction. PCRs were carried out to analyze the PAX7 5'-5' cassette and PAX7 3'-5' cassette junctions in transfected HEK293 cells through agarose gel electrophoresis. The PAX7-X2 primers were used along with the PGK-rev primer for amplification. Marker ladder bands are denoted for reference. Expected band sizes for 5'-5' junctions: r1-1 + r1-2 = 1188 bp; r1-1 + r1-4 = 1233 bp; r1-2 + r1-3 =1188 bp; r1-3 + r1-4 = 1233 bp; r2-1 = 1595 bp; r3-2 = 808 bp; r2-1 + r3-2 = 808 bp. Expected band sizes for 3'-5' junctions: r1-1 + r1-2 = 1028 bp; r1-1 + r1-4 = 1028 bp; r1-2 + r1-3 =1036 bp; r1-3 + r1-4 = 1036 bp; r2-1 = 929 bp; r3-2 = 1716 bp; r2-1 + r3-2 = 929 bp. PCR was performed to analyze the H11 5'-5' pKER cassette junction and the H11 locus of sorted JF10 hiPSCs transfected with pKER-mKOκ cassettes and the H11 PAMs Out sgRNA pair with Cas9-DD or DD-Cas9 in the presence or absence of Shield-1. The primers H11-x1-fwd and mKOk-AS-N2 were used to amplify the H11 5'-5' cassette junction and the primers H11-X1-fwd and H11-X1-rev were used to amplify the H11 locus. Gel electrophoresis was performed to visualize bands. The expected band size of the H11 5'-5' mKOκ cassette junction is 898 bp. The expected band size of the unmodified H11 locus is 992 bp and the expected size of the KiBL allele is 2233 bp.
Site Name
